Company profile: Vector BioMed
1.1 - Company Overview
Company description
- Provider of state-of-the-art custom vector design and GMP manufacturing, specializing in Lentiviral vector production for research, pre-clinical, IND-enabling, and clinical trials using a serum-free, chemically-defined process; algorithm-based vector design optimized for titer, transduction, and transgene expression; custom assay development; and support services for clinical development and commercialization.
Products and services
- GMP Lentiviral Vector Manufacturing: Constructs GMP-compliant Lentiviral vectors for clinical trials using a serum-free, chemically-defined process for clinical production
- Algorithm-Based Vector Design: Architects algorithm-driven Lentiviral vectors optimized for titer, transduction, and transgene expression parameters
- Pre-Clinical Lentiviral Vector Production: Produces IND-enabling Lentiviral vectors for pre-clinical research and IND-enabling studies supporting pre-clinical evaluation
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Vector BioMed
PlasmidFactory
HQ: Germany
Website
- Description: Provider of contract manufacturing for plasmid and minicircle DNA, serving cancer research, gene and cell therapy, CAR T-cell development, and vaccination. Offerings include plasmid DNA production, minicircle DNA vectors, capillary gel electrophoresis quality control, GMP-compliant long-term DNA storage, and R&D services in plasmid and minicircle DNA technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PlasmidFactory company profile →
Nightstar Therapeutics
HQ: United Kingdom
Website
- Description: Provider of biopharmaceutical gene therapy research and development focused on retinal dystrophies, aiming to enable treatments for rare conditions caused by single-gene mutations; U.K. startup.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nightstar Therapeutics company profile →
Arrayit
HQ: United States
Website
- Description: Provider of proprietary life science technologies and consumables for disease prevention, treatment, and cure, including DNA microarrays for gene expression and genotyping, protein microarrays (antigens, antibodies, peptides), microarrayers (manufacturing robots), microarray software for controller, quantification, analysis, and design, microarray tools (pins, printheads, hybridization cassettes), and microarray scanners (colorimetric, CCD, sub-micron fluorescence).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arrayit company profile →
GeneDx
HQ: United States
Website
- Description: Provider of genomic diagnostics and data science solutions using artificial intelligence and machine learning to deliver personalized, actionable insights that improve health outcomes. Offers XomeDxXpress rapid whole exome sequencing (provisional results in 7 days, full report in 2 weeks), whole genome sequencing with optional trio testing, and genetic counseling services for patients and healthcare providers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GeneDx company profile →
OncoMark
HQ: Ireland
Website
- Description: Provider of companion diagnostic tests for cancer patient stratification. An Irish UCD spin-out, the company develops diagnostics to support cancer drug development, enabling pharmaceutical companies to select patients for whom a drug may be particularly effective, and tests that can also be used during clinical trials to help reduce the numbers of patients required.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OncoMark company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Vector BioMed
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Vector BioMed
2.2 - Growth funds investing in similar companies to Vector BioMed
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Vector BioMed
4.2 - Public trading comparable groups for Vector BioMed
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →